It is a pharma private limited company based in Palghar, Maharashtra, India, established in 1990.
1990 | Palghar, Maharashtra, India | ActiveSapphire Lifesciences Private Limited, a active private limited company, was established on 26 February 1990 in Palghar, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1990PTC055572. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹13.50 Cr and a paid-up capital of ₹13.34 Cr.
Formerly known as Saphire Lifesciences Private Limited, Saphire Capules Private Limited. It upholds a compliant status. Its leadership includes Parag Kishor Shah (Director), Ganesh Shenoy Baburaya (Director). Past directors included Agnello Edward Fernandez, Ganesh Shenoy Baburaya. It holds ₹15.76 Cr open charges and ₹7.22 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 44 & 45, Palghar Taluka Ind. Co-Op Estate Ltd., Boisar Road, Palghar, Palghar, Maharashtra, 401404.
U24239MH1990PTC055572
055572
26 February 1990
₹13.50 Cr
₹13.34 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sapphire Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Parag Kishor Shah | Director | 30 Mar 2004 | Current |
| Ganesh Shenoy Baburaya | Director | 27 Nov 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2022 | Past |
| Pramod Abcsdd | Director | 31 Mar 2004 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sapphire Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.93% decrease. The company also saw a substantial improvement in profitability, with a 14.78% increase in profit. The company's net worth Soared by an impressive increase of 35.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Sapphire Lifesciences had a promoter holding of 92.87% and a public holding of 7.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹157,600,000.00
₹72,202,460.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2017 | Others | ₹3.00 Cr | Open |
| 28 Feb 2013 | Others | ₹12.76 Cr | Open |
| 03 Sep 2020 | Others | ₹8.18 M | Satisfied |
| 26 May 2020 | Others | ₹1.25 Cr | Satisfied |
| 30 Dec 2015 | Central Bank Of India | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sapphire Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sapphire Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapphire Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 12.76 Cr registered on 28 Feb 2013 with Charge ID 10410241 was modified on 30 Jul 2025. was recorded as a recent event.
Progress on Sapphire Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Sapphire Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
A charge registered on 26 May 2020 via Charge ID 100338769 with Others was fully satisfied on 30 Mar 2023. was recorded as a recent event.
Progress on A charge registered on 03 Sep 2020 via Charge ID 100385849 with Others was fully satisfied on 24 Mar 2021. was documented.
A charge with Others amounted to Rs. 0.82 Cr with Charge ID 100385849 was registered on 03 Sep 2020. was recorded as a recent event.
The CIN of Sapphire Lifesciences Private Limited is U24239MH1990PTC055572.
Sapphire Lifesciences Private Limited is headquartered at Plot No. 44 & 45, Palghar Taluka Ind. Co-Op Estate Ltd., Boisar Road, Palghar, Palghar, Maharashtra, 401404.
Sapphire Lifesciences Private Limited was incorporated on 26 February 1990.
The current directors of Sapphire Lifesciences Private Limited are
The primary industry of Sapphire Lifesciences Private Limited is Manufacturing.
Sapphire Lifesciences Private Limited is unlisted.
The authorized capital of Sapphire Lifesciences Private Limited is ₹13.50 Cr, and the paid-up capital is ₹13.34 Cr.
The compliance status of Sapphire Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX